Skip to content
10-Q

Quarterly Report

KUVATRIS THERAPEUTICS, INC.

0001493152-26-002270

← back to feed
Filed
Jan 14, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Jan 13, 2026 126.26M sh
Shares Diluted Q3 2024 · Sep 30, 2024 9.06M sh
Shares Diluted Q3 2024 · Sep 30, 2024 8.05M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 971.77K sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 859.46K sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$5M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$8.15M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$1.93M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$1.81M
Stockholders Equity Q3 2024 · Dec 31, 2023 $3.39M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$536.92K
Stockholders Equity Q3 2024 · Jun 30, 2023 $2.27M
Stockholders Equity Q3 2024 · Dec 31, 2022 $108.8K
Current Liabilities Q3 2024 · Sep 30, 2024 $2.25M
Current Liabilities Q3 2024 · Dec 31, 2023 $1.8M
Total Liabilities Q3 2024 · Sep 30, 2024 $2.75M
Total Liabilities Q3 2024 · Dec 31, 2023 $2.3M
Current Assets Q3 2024 · Sep 30, 2024 $820.38K
Current Assets Q3 2024 · Dec 31, 2023 $5.68M
Total Assets Q3 2024 · Sep 30, 2024 $820.38K
Total Assets Q3 2024 · Dec 31, 2023 $5.68M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.95
Eps Diluted Q3 2024 · Sep 30, 2023 −$5.20
Eps Diluted Q3 2024 · Sep 30, 2023 −$14.39
Eps Basic Q3 2024 · Sep 30, 2024 −$0.10
Eps Basic Q3 2024 · Sep 30, 2024 −$0.95
Eps Basic Q3 2024 · Sep 30, 2023 −$5.20
Eps Basic Q3 2024 · Sep 30, 2023 −$14.39
Sga Expense Q3 2024 · Sep 30, 2024 $771.01K
Sga Expense Q3 2024 · Sep 30, 2024 $5.56M
Sga Expense Q3 2024 · Sep 30, 2023 $2.43M
Sga Expense restated Q3 2024 · Sep 30, 2023 $8.96M
Rd Expense Q3 2024 · Sep 30, 2024 $116.93K
Rd Expense Q3 2024 · Sep 30, 2024 $2.02M
Rd Expense Q3 2024 · Sep 30, 2023 $1.94M
Rd Expense Q3 2024 · Sep 30, 2023 $2.75M
Net Income Q3 2024 · Sep 30, 2024 −$876.64K
Net Income Q3 2024 · Sep 30, 2024 −$7.57M
Net Income Q3 2024 · Sep 30, 2023 −$5.05M
Net Income Q3 2024 · Sep 30, 2023 −$12.37M
Operating Income Q3 2024 · Sep 30, 2024 −$887.94K
Operating Income Q3 2024 · Sep 30, 2024 −$7.58M
Operating Income Q3 2024 · Sep 30, 2023 −$4.36M
Operating Income restated Q3 2024 · Sep 30, 2023 −$11.71M